Acadia Pharmaceuticals
Elizabeth G. is a seasoned professional in drug safety and pharmacovigilance with extensive experience in the pharmaceutical industry. Currently serving as the Senior Director of Drug Safety & Pharmacovigilance and Head of PV Operations at Acadia Pharmaceuticals Inc. since April 2024, Elizabeth has previously held significant roles, including Director of Pharmacovigilance at G1 Therapeutics, Inc. from January 2022 to April 2024, and Associate Director at Sunovion Pharmaceuticals, where responsibilities encompassed compliance, training, and strategic alliances. Elizabeth G. also founded Elizabeth Garcia Pharmacovigilance Consulting, LLC, and has worked with various companies, including Acorda Therapeutics, OSI Pharmaceuticals, and Forest Laboratories, in drug safety capacities. Educational background includes studies at Chamberlain University.
This person is not in any teams
This person is not in any offices
Acadia Pharmaceuticals
3 followers
Acadia is trailblazing breakthroughs in neuroscience to elevate life. They are at the forefront of healthcare, fighting for breakthroughs in our science, their therapies and the way we work, but also in the lives of the people they serve. Acadia is committed to their purpose: we fight disease so more you shines through.